ImageneBio (IMA)
Develops IMG-007 for autoimmune and inflammatory diseases.
$5.01
At close−0.01 (−0.20%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions39 holders · as of Mar 31, 2026 | 47.18% | 5.36M shares | |
| Insiders10 holders · as of Aug 17, 2026 | 24.80% | 2.82M shares | |
| Otherremainder | 28.02% | 3.18M shares |
11.35M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
39 holders · 5.36M shares · 7 new positions · 24 increased · 6 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BVF Inc/IL | 1.11M | 9.78% | +307.9K | May 15, 2026 |
| Blue Owl Capital Holdings LP | 959.3K | 8.45% | +135.6K | May 14, 2026 |
| Cable Car Capital LLC | 754.7K | 6.65% | +110.8K | May 15, 2026 |
| Omega Fund Management, LLC | 455.4K | 4.01% | 0 | May 15, 2026 |
| Orbimed Advisors LLC | 378.6K | 3.33% | 0 | May 15, 2026 |
| RTW Investments, LP | 334.4K | 2.95% | 0 | May 15, 2026 |
| Vanguard Capital Management LLC | 325.2K | 2.86% | +325.2Knew | May 15, 2026 |
| BML Capital Management, LLC | 200.7K | 1.77% | +23.7K | May 6, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLCincl. Orbimed Capital LLC, OrbiMed Genesis GP LLC +1 more | 13.10% | 1.50M | 13D | Apr 29, 2026 ↗ |
| Trails Edge Capital Partners, LP | 9.90% | 1.18M | 13G | Apr 21, 2026 ↗ |
| Blue Owl Capital Holdings LP | 8.51% | 959.3K | 13G | May 14, 2026 ↗ |
| Leonard Braden Michaelincl. BML Investment Partners, L.P. | 8.50% | 13D | Jun 16, 2025 ↗ | |
| Otello Stampacchiaincl. Omega Fund VI, L.P., Claudio Nessi +2 more | 8.40% | 936.2K | 13D | Apr 21, 2026 ↗ |
| Funicular Funds, LP | 5.80% | 643.9K | 13G | Jan 6, 2026 ↗ |
| Biotechnology Value Fund L P | 5.30% | 593.2K | 13G | May 15, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 17, 2026 | Robert B. Lallyofficer: Principal Accounting Officer | Sale | 1,525 | $5.34 | 55,582 |
| Jul 16, 2026 | Robert B. Lallyofficer: Principal Accounting Officer | Sale | 1,671 | $5.50 | 57,107 |
| Apr 14, 2026 | Orbimed Advisors LLCdirector | Purchase · 2 lots | 721,292 | $0.0010 | 384,689 |
| Apr 14, 2026 | David P. Bonitadirector | Purchase · 2 lots | 721,292 | $0.0010 | 384,689 |
| Dec 24, 2025 | Joseph P. Slatterydirector | Purchase | 16,000 | $5.99 | 16,000 |
CongressHouse and Senate disclosures
Not reported.